Official SEC submissions

Aprea Therapeutics SEC Filings

Direct answer

Aprea Therapeutics's latest SEC filing is 8-K.

It was filed on August 28, 2026, and 40 recent filings are available.

Each row links directly to the SEC document and filing index.

Official SEC EDGAR submissions

Get free Aprea Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Recent SEC filings

8-K

Current report

Filed: 2026-08-28

Report date: 2026-08-28

8-K

Open SEC document View filing index

10-Q

Periodic report

Filed: 2026-08-12

Report date: 2026-06-30

10-Q

Open SEC document View filing index

8-K

Current report

Filed: 2026-08-12

Report date: 2026-08-12

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-07-23

Report date: 2026-07-23

FORM 8-K

Open SEC document View filing index

Insider transaction

Filed: 2026-06-17

Report date: 2026-06-16

OWNERSHIP DOCUMENT

Open SEC document View filing index

Insider transaction

Filed: 2026-06-17

Report date: 2026-06-16

OWNERSHIP DOCUMENT

Open SEC document View filing index

Insider transaction

Filed: 2026-06-17

Report date: 2026-06-16

OWNERSHIP DOCUMENT

Open SEC document View filing index

Insider transaction

Filed: 2026-06-17

Report date: 2026-06-16

OWNERSHIP DOCUMENT

Open SEC document View filing index

Insider transaction

Filed: 2026-06-17

Report date: 2026-06-16

OWNERSHIP DOCUMENT

Open SEC document View filing index

Insider transaction

Filed: 2026-06-17

Report date: 2026-06-16

OWNERSHIP DOCUMENT

Open SEC document View filing index

Insider transaction

Filed: 2026-06-17

Report date: 2026-06-16

OWNERSHIP DOCUMENT

Open SEC document View filing index

Insider transaction

Filed: 2026-06-17

Report date: 2026-06-16

OWNERSHIP DOCUMENT

Open SEC document View filing index

8-K

Current report

Filed: 2026-06-17

Report date: 2026-06-16

FORM 8-K

Open SEC document View filing index

10-Q

Periodic report

Filed: 2026-05-13

Report date: 2026-03-31

10-Q

Open SEC document View filing index

8-K

Current report

Filed: 2026-05-13

Report date: 2026-05-13

8-K

Open SEC document View filing index

DEFA14A

Proxy statement

Filed: 2026-04-30

DEFA14A

Open SEC document View filing index

DEF 14A

Proxy statement

Filed: 2026-04-30

Report date: 2026-06-16

DEF 14A

Open SEC document View filing index

Insider transaction

Filed: 2026-04-01

Report date: 2026-03-31

OWNERSHIP DOCUMENT

Open SEC document View filing index

Insider transaction

Filed: 2026-04-01

Report date: 2026-03-31

OWNERSHIP DOCUMENT

Open SEC document View filing index

8-K

Current report

Filed: 2026-04-01

Report date: 2026-04-01

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-03-30

Report date: 2026-03-30

FORM 8-K

Open SEC document View filing index

Insider transaction

Filed: 2026-03-16

Report date: 2026-03-12

OWNERSHIP DOCUMENT

Open SEC document View filing index

Insider transaction

Filed: 2026-03-16

Report date: 2026-03-12

OWNERSHIP DOCUMENT

Open SEC document View filing index

10-K

Periodic report

Filed: 2026-03-16

Report date: 2025-12-31

10-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-03-16

Report date: 2026-03-16

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-02-18

Report date: 2026-02-18

FORM 8-K

Open SEC document View filing index

Insider transaction

Filed: 2026-02-02

Report date: 2026-01-30

OWNERSHIP DOCUMENT

Open SEC document View filing index

Insider transaction

Filed: 2026-02-02

Report date: 2026-01-30

OWNERSHIP DOCUMENT

Open SEC document View filing index

8-K

Current report

Filed: 2026-01-29

Report date: 2026-01-28

FORM 8-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-01-23

Report date: 2026-01-23

FORM 8-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-01-09

Report date: 2026-01-09

8-K

Open SEC document View filing index

Insider transaction

Filed: 2025-12-11

Report date: 2025-12-10

OWNERSHIP DOCUMENT

Open SEC document View filing index

Insider transaction

Filed: 2025-12-11

Report date: 2025-12-10

OWNERSHIP DOCUMENT

Open SEC document View filing index

Insider transaction

Filed: 2025-12-11

Report date: 2025-12-10

OWNERSHIP DOCUMENT

Open SEC document View filing index

8-K

Current report

Filed: 2025-12-09

Report date: 2025-12-08

FORM 8-K

Open SEC document View filing index

10-Q

Periodic report

Filed: 2025-11-12

Report date: 2025-09-30

10-Q

Open SEC document View filing index

8-K

Current report

Filed: 2025-11-12

Report date: 2025-11-12

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2025-10-24

Report date: 2025-10-24

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2025-10-15

Report date: 2025-10-15

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2025-09-08

Report date: 2025-09-08

8-K

Open SEC document View filing index

Verified data

Recent filing categories: 4
Recent filings: 40
SEC CIK: 0001781983
Latest filing date: August 28, 2026

Explore related company data

View the Aprea Therapeutics company profile View Aprea Therapeutics annual financials